Guided Therapeutics (GTHP) Inventory Average (2012 - 2025)
Guided Therapeutics (GTHP) reported Inventory Average of $515500.0 for Q4 2025, down 18.75% on a YoY basis from $634500.0 in Q4 2024, and down 12.48% sequentially from $589000.0 in Q3 2025.
Guided Therapeutics (GTHP) Inventory Average (2012 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 14 years of Inventory Average data on file, last reported at $515500.0 in Q4 2025.
- For the quarter ending Q4 2025, Inventory Average fell 18.75% year-over-year to $515500.0; the trailing twelve-month figure through Dec 2025 stood at $515500.0 (down 18.75% YoY), and the FY2025 full-year result was $540500.0, down 14.55% from the prior year.
- Inventory Average declined to $515500.0 in Q4 2025, from $589000.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $640000.0 in Q4 2023 to a low of $515500.0 in Q4 2025.
- A 5-year average of $599475.0 and a median of $608000.0 in 2021 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average surged 1074.04% in 2021 and slipped 18.75% in 2025, its largest moves.
- Tracing GTHP's Inventory Average over 5 years: stood at $580500.0 in 2021, then fell by 1.46% to $572000.0 in 2022, then increased by 11.89% to $640000.0 in 2023, then dropped by 0.86% to $634500.0 in 2024, then fell by 18.75% to $515500.0 in 2025.
- Business Quant data shows GTHP's Inventory Average at $515500.0 in Q4 2025, $589000.0 in Q3 2025, and $614000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.13 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 661.35 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.49 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 2.29 Bn |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | 515,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 515,500.00 |
| Sep 30, 2025 | 589,000.00 |
| Jun 30, 2025 | 614,000.00 |
| Mar 31, 2025 | 633,000.00 |
| Dec 31, 2024 | 634,500.00 |
| Sep 30, 2024 | 634,000.00 |
| Jun 30, 2024 | 632,000.00 |
| Mar 31, 2024 | 632,000.00 |
| Dec 31, 2023 | 640,000.00 |
| Sep 30, 2023 | 610,500.00 |
| Jun 30, 2023 | 579,000.00 |
| Mar 31, 2023 | 566,500.00 |
| Dec 31, 2022 | 572,000.00 |
| Sep 30, 2022 | 582,500.00 |
| Jun 30, 2022 | 569,500.00 |
| Mar 31, 2022 | 570,500.00 |
| Dec 31, 2021 | 580,500.00 |
| Sep 30, 2021 | 610,500.00 |
| Jun 30, 2021 | 618,500.00 |
| Mar 31, 2021 | 605,500.00 |